Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 33 of 33 entries
Sorted by: Best Match Show Resources per page
A reliable fossa ovalis impedance mapping for safer transseptal puncture: A new vision beyond voltage.

Journal of cardiovascular electrophysiology

Pentimalli F, Cornara S, Astuti M, Bacino L, Somaschini A, Mazzucchi P, Buscaglia E, Cordone S, Ghione M, Errigo D, Bellone P.
PMID: 34664750
J Cardiovasc Electrophysiol. 2021 Dec;32(12):3270-3274. doi: 10.1111/jce.15272. Epub 2021 Oct 24.

INTRODUCTION: Transseptal puncture (TSP) is widely used in clinical practice but is negatively affected by a nonneglectable rate of complications and X-ray exposure. To address these problems, we investigated whether or not impedance mapping could correctly identify fossa ovalis...

Cite
Pentimalli F, Cornara S, Astuti M, et al. A reliable fossa ovalis impedance mapping for safer transseptal puncture: A new vision beyond voltage. J Cardiovasc Electrophysiol. 2021;32(12):3270-3274doi: 10.1111/jce.15272.
Pentimalli, F., Cornara, S., Astuti, M., Bacino, L., Somaschini, A., Mazzucchi, P., Buscaglia, E., Cordone, S., Ghione, M., Errigo, D., & Bellone, P. (2021). A reliable fossa ovalis impedance mapping for safer transseptal puncture: A new vision beyond voltage. Journal of cardiovascular electrophysiology, 32(12), 3270-3274. https://doi.org/10.1111/jce.15272
Pentimalli, Francesco, et al. "A reliable fossa ovalis impedance mapping for safer transseptal puncture: A new vision beyond voltage." Journal of cardiovascular electrophysiology vol. 32,12 (2021): 3270-3274. doi: https://doi.org/10.1111/jce.15272
Pentimalli F, Cornara S, Astuti M, Bacino L, Somaschini A, Mazzucchi P, Buscaglia E, Cordone S, Ghione M, Errigo D, Bellone P. A reliable fossa ovalis impedance mapping for safer transseptal puncture: A new vision beyond voltage. J Cardiovasc Electrophysiol. 2021 Dec;32(12):3270-3274. doi: 10.1111/jce.15272. Epub 2021 Oct 24. PMID: 34664750.
Copy Download .nbib Format: NLM
Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.

European heart journal

Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E, Calò L, Mascia G, Mont L, Vernooy K, van Dijk V, Allaart C, Fauchier L, Gasparini M, Parati G, Soranna D, Rienstra M, Van Gelder IC.
PMID: 34878510
Eur Heart J. 2021 Dec 08; doi: 10.1093/eurheartj/ehab831. Epub 2021 Dec 08.

No abstract available.

Cite
Brignole M, Pentimalli F, Palmisano P, et al. Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab831.
Brignole, M., Pentimalli, F., Palmisano, P., Landolina, M., Quartieri, F., Occhetta, E., Calò, L., Mascia, G., Mont, L., Vernooy, K., van Dijk, V., Allaart, C., Fauchier, L., Gasparini, M., Parati, G., Soranna, D., Rienstra, M., & Van Gelder, I. C. (2021). Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. European heart journal, . https://doi.org/10.1093/eurheartj/ehab831
Brignole, Michele, et al. "Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab831
Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E, Calò L, Mascia G, Mont L, Vernooy K, van Dijk V, Allaart C, Fauchier L, Gasparini M, Parati G, Soranna D, Rienstra M, Van Gelder IC. Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021 Dec 08; doi: 10.1093/eurheartj/ehab831. Epub 2021 Dec 08. PMID: 34878510.
Copy Download .nbib Format: NLM
[Contribution to the pathogenesis of leukemia].

Tumori

PENTIMALLI F.
PMID: 13090341
Tumori. 1953 Mar-Apr;39(2):87-115.

No abstract available.

Cite
PENTIMALLI F. Un contributo alla patogenesi delle leucemie. [Contribution to the pathogenesis of leukemia]. Tumori. 1953;39(2):87-115
PENTIMALLI, F. (1953). Un contributo alla patogenesi delle leucemie. [Contribution to the pathogenesis of leukemia]. Tumori, 39(2), 87-115.
PENTIMALLI, F. "Un contributo alla patogenesi delle leucemie." [Contribution to the pathogenesis of leukemia]. Tumori vol. 39,2 (1953): 87-115.
PENTIMALLI F. Un contributo alla patogenesi delle leucemie. [Contribution to the pathogenesis of leukemia]. Tumori. 1953 Mar-Apr;39(2):87-115. Undetermined. PMID: 13090341.
Copy Download .nbib Format: NLM
[Present trends in the chemotherapy of tumors].

Giornale italiano di chemioterapia

PENTIMALLI F.
PMID: 13462162
G Ital Chemioter. 1956 Jul-Dec;3(3):130-45.

No abstract available.

Cite
PENTIMALLI F. Attuali orientamenti di chemioterapia dei tumori. [Present trends in the chemotherapy of tumors]. G Ital Chemioter. 1956;3(3):130-45
PENTIMALLI, F. (1956). Attuali orientamenti di chemioterapia dei tumori. [Present trends in the chemotherapy of tumors]. Giornale italiano di chemioterapia, 3(3), 130-45.
PENTIMALLI, F. "Attuali orientamenti di chemioterapia dei tumori." [Present trends in the chemotherapy of tumors]. Giornale italiano di chemioterapia vol. 3,3 (1956): 130-45.
PENTIMALLI F. Attuali orientamenti di chemioterapia dei tumori. [Present trends in the chemotherapy of tumors]. G Ital Chemioter. 1956 Jul-Dec;3(3):130-45. Italian. PMID: 13462162.
Copy Download .nbib Format: NLM
Dynamics of the Sphere Model of Consciousness: Silence, Space, and Self.

Frontiers in psychology

Pintimalli A, Di Giuseppe T, Serantoni G, Glicksohn J, Ben-Soussan TD.
PMID: 33071865
Front Psychol. 2020 Sep 18;11:548813. doi: 10.3389/fpsyg.2020.548813. eCollection 2020.

The

Cite
Pintimalli A, Di Giuseppe T, Serantoni G, et al. Dynamics of the Sphere Model of Consciousness: Silence, Space, and Self. Front Psychol. 2020;11:548813doi: 10.3389/fpsyg.2020.548813.
Pintimalli, A., Di Giuseppe, T., Serantoni, G., Glicksohn, J., & Ben-Soussan, T. D. (2020). Dynamics of the Sphere Model of Consciousness: Silence, Space, and Self. Frontiers in psychology, 11548813. https://doi.org/10.3389/fpsyg.2020.548813
Pintimalli, Andrea, et al. "Dynamics of the Sphere Model of Consciousness: Silence, Space, and Self." Frontiers in psychology vol. 11 (2020): 548813. doi: https://doi.org/10.3389/fpsyg.2020.548813
Pintimalli A, Di Giuseppe T, Serantoni G, Glicksohn J, Ben-Soussan TD. Dynamics of the Sphere Model of Consciousness: Silence, Space, and Self. Front Psychol. 2020 Sep 18;11:548813. doi: 10.3389/fpsyg.2020.548813. eCollection 2020. PMID: 33071865; PMCID: PMC7530372.
Copy Download .nbib Format: NLM
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.

Cell death & disease

Costa C, Indovina P, Mattioli E, Forte IM, Iannuzzi CA, Luzzi L, Bellan C, De Summa S, Bucci E, Di Marzo D, De Feo M, Mutti L, Pentimalli F, Giordano A.
PMID: 33067416
Cell Death Dis. 2020 Oct 16;11(10):867. doi: 10.1038/s41419-020-03016-5.

Author Francesca Pentimalli was incorrectly associated with Histopathological Unit, IRCCS-Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy. The author's actual affiliation is Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, I-80131 Napoli, Italy.

Cite
Costa C, Indovina P, Mattioli E, et al. Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma. Cell Death Dis. 2020;11(10):867doi: 10.1038/s41419-020-03016-5.
Costa, C., Indovina, P., Mattioli, E., Forte, I. M., Iannuzzi, C. A., Luzzi, L., Bellan, C., De Summa, S., Bucci, E., Di Marzo, D., De Feo, M., Mutti, L., Pentimalli, F., & Giordano, A. (2020). Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma. Cell death & disease, 11(10), 867. https://doi.org/10.1038/s41419-020-03016-5
Costa, Caterina, et al. "Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma." Cell death & disease vol. 11,10 (2020): 867. doi: https://doi.org/10.1038/s41419-020-03016-5
Costa C, Indovina P, Mattioli E, Forte IM, Iannuzzi CA, Luzzi L, Bellan C, De Summa S, Bucci E, Di Marzo D, De Feo M, Mutti L, Pentimalli F, Giordano A. Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma. Cell Death Dis. 2020 Oct 16;11(10):867. doi: 10.1038/s41419-020-03016-5. PMID: 33067416; PMCID: PMC7567790.
Copy Download .nbib Format: NLM
The Oncolytic Virus .

Frontiers in oncology

Di Somma S, Iannuzzi CA, Passaro C, Forte IM, Iannone R, Gigantino V, Indovina P, Botti G, Giordano A, Formisano P, Portella G, Malfitano AM, Pentimalli F.
PMID: 31355131
Front Oncol. 2019 Jul 12;9:564. doi: 10.3389/fonc.2019.00564. eCollection 2019.

No abstract available.

Cite
Di Somma S, Iannuzzi CA, Passaro C, et al. The Oncolytic Virus . Front Oncol. 2019;9:564doi: 10.3389/fonc.2019.00564.
Di Somma, S., Iannuzzi, C. A., Passaro, C., Forte, I. M., Iannone, R., Gigantino, V., Indovina, P., Botti, G., Giordano, A., Formisano, P., Portella, G., Malfitano, A. M., & Pentimalli, F. (2019). The Oncolytic Virus . Frontiers in oncology, 9564. https://doi.org/10.3389/fonc.2019.00564
Di Somma, Sarah, et al. "The Oncolytic Virus ." Frontiers in oncology vol. 9 (2019): 564. doi: https://doi.org/10.3389/fonc.2019.00564
Di Somma S, Iannuzzi CA, Passaro C, Forte IM, Iannone R, Gigantino V, Indovina P, Botti G, Giordano A, Formisano P, Portella G, Malfitano AM, Pentimalli F. The Oncolytic Virus . Front Oncol. 2019 Jul 12;9:564. doi: 10.3389/fonc.2019.00564. eCollection 2019. PMID: 31355131; PMCID: PMC6639422.
Copy Download .nbib Format: NLM
Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.

European heart journal

Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E, Calò L, Mascia G, Mont L, Vernooy K, van Dijk V, Allaart C, Fauchier L, Gasparini M, Parati G, Soranna D, Rienstra M, Van Gelder IC.
PMID: 34878510
Eur Heart J. 2021 Dec 08; doi: 10.1093/eurheartj/ehab831. Epub 2021 Dec 08.

No abstract available.

Cite
Brignole M, Pentimalli F, Palmisano P, et al. Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab831.
Brignole, M., Pentimalli, F., Palmisano, P., Landolina, M., Quartieri, F., Occhetta, E., Calò, L., Mascia, G., Mont, L., Vernooy, K., van Dijk, V., Allaart, C., Fauchier, L., Gasparini, M., Parati, G., Soranna, D., Rienstra, M., & Van Gelder, I. C. (2021). Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. European heart journal, . https://doi.org/10.1093/eurheartj/ehab831
Brignole, Michele, et al. "Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab831
Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E, Calò L, Mascia G, Mont L, Vernooy K, van Dijk V, Allaart C, Fauchier L, Gasparini M, Parati G, Soranna D, Rienstra M, Van Gelder IC. Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021 Dec 08; doi: 10.1093/eurheartj/ehab831. Epub 2021 Dec 08. PMID: 34878510.
Copy Download .nbib Format: NLM
AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.

European heart journal

Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E, Calò L, Mascia G, Mont L, Vernooy K, van Dijk V, Allaart C, Fauchier L, Gasparini M, Parati G, Soranna D, Rienstra M, Van Gelder IC.
PMID: 34453840
Eur Heart J. 2021 Dec 07;42(46):4731-4739. doi: 10.1093/eurheartj/ehab569.

AIMS : In patients with atrial fibrillation (AF) and heart failure (HF), strict and regular rate control with atrioventricular junction ablation and biventricular pacemaker (Ablation + CRT) has been shown to be superior to pharmacological rate control in reducing...

Cite
Brignole M, Pentimalli F, Palmisano P, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021;42(46):4731-4739doi: 10.1093/eurheartj/ehab569.
Brignole, M., Pentimalli, F., Palmisano, P., Landolina, M., Quartieri, F., Occhetta, E., Calò, L., Mascia, G., Mont, L., Vernooy, K., van Dijk, V., Allaart, C., Fauchier, L., Gasparini, M., Parati, G., Soranna, D., Rienstra, M., Van Gelder, I. C. (2021). AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. European heart journal, 42(46), 4731-4739. https://doi.org/10.1093/eurheartj/ehab569
Brignole, Michele, et al. "AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial." European heart journal vol. 42,46 (2021): 4731-4739. doi: https://doi.org/10.1093/eurheartj/ehab569
Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E, Calò L, Mascia G, Mont L, Vernooy K, van Dijk V, Allaart C, Fauchier L, Gasparini M, Parati G, Soranna D, Rienstra M, Van Gelder IC. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021 Dec 07;42(46):4731-4739. doi: 10.1093/eurheartj/ehab569. PMID: 34453840.
Copy Download .nbib Format: NLM
Showing 25 to 33 of 33 entries